<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16(6)</volume><submitter>Park J</submitter><funding>Ministry of Science and ICT</funding><funding>National Research Foundation of Korea</funding><journal>Pharmaceutics</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11207964</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>In Vivo Evaluation of 68Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model</pubmed_title><pmcid>PMC11207964</pmcid><funding_grant_id>2020M2D9A1093991</funding_grant_id><funding_grant_id>50462-2024</funding_grant_id><funding_grant_id>2023R1A2C1007307</funding_grant_id><pubmed_authors>Cho Y</pubmed_authors><pubmed_authors>Lim S</pubmed_authors><pubmed_authors>Kang W</pubmed_authors><pubmed_authors>Park J</pubmed_authors><pubmed_authors>Lim J</pubmed_authors><pubmed_authors>Lee Y</pubmed_authors><pubmed_authors>Kang J</pubmed_authors><pubmed_authors>Lee T</pubmed_authors><pubmed_authors>Lee D</pubmed_authors></additional><is_claimable>false</is_claimable><name>In Vivo Evaluation of 68Ga-Labeled NOTA-EGFRvIII Aptamer in EGFRvIII-Positive Glioblastoma Xenografted Model</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2025-04-04T21:22:01.873Z</modification><creation>2025-04-04T21:22:01.873Z</creation></dates><accession>S-EPMC11207964</accession><cross_references/></HashMap>